ALFA Finder
17:22 IST
BSE
Share Pledge
Symbiotec Pharmalab Share Pledge
Promoters of Symbiotec Pharmalab submitted a revised disclosure to update the lender and trustee names for their pledged share encumbrance.
Symbiotec Pharmalab Ltd
- Share price
- ₹1,538.60
- Market cap
- ₹9,886 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Earnings Call 4Share Pledge 2Results Update 2Board Meeting Date 2Financial Results 1Capital Structure Change 1Business Update 1
Time
2 announcements with these filters
12:30 IST
BSE
Share Pledge
Symbiotec Pharmalab Share Pledge
Symbiotec Pharmalab promoters pledged 34.93 lakh shares (~5.44%) to debenture trustee Beacon Trusteeship. This Securitisation encumbrance secures the company's debenture issue.